Wyeth/Elan Submit Pharmacogenomics Study Report From Alzheimer’s Trial To FDA

A gene expression study based on blood samples from a failed vaccine candidate trial could help develop other potential therapies, Wyeth says.

More from Archive

More from Pink Sheet